Vaxart Q3 Earnings Call Highlights
Vaxart Inc VXRT
$0.37
β² +0.00%
(+$0.00)
Open
$0.37
Prev Close
$0.37
Day Range
$0.37 β $0.39
52W Range
$0.33 β $0.84
Market Cap
$104.42M
P/E (TTM)
2.34
Beta
1.31
EPS (TTM)
$0.16
π Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | OTC MARKETS |
| Currency | USD |
| IPO Date | 1980-03-17 |
| Shares Out. | 242,840,000 |
| Website | vaxart.com/ β |
| Phone | 16505503500 |
Vaxart Inc is a publicly traded company under the ticker symbol VXRT on the OTC MARKETS, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
8 analysts (2026-11-01)
π° Latest News for VXRT
Vaxart, Inc. (VXRT) Q3 2026 Earnings Call Transcript
Vaxart Inc (VXRT) (Q3 2026) Earnings Call Highlights: Cash Runway Into Q2 2027, COVID-19 ...
VAXART, INC. (VXRT) Reports Q3 Loss, Beats Revenue Estimates
Vaxart Provides Business Update and Reports Third Quarter 2026 Financial Results
Vaxart Q3 EPS $(0.07) Down From $(0.04) YoY, Sales $10.620M Down From $72.413M YoY
electroCore, Inc. (ECOR) Reports Q3 Loss, Misses Revenue Estimates
USANA Health Sciences (USNA) Reports Q3 Loss, Lags Revenue Estimates
